Chester A. Mathis | |
---|---|
Education |
Humboldt State University B.Sc. (1972) UC Davis Ph.D. (1979) |
Awards |
Metlife Foundation Award for Medical Research in Alzheimer's Disease
[1] (2004) Potamkin Prize (2008) Reagan Institute Award (2009) |
Scientific career | |
Institutions | University of Pittsburgh Medical Center |
Chester Mathis is an American chemist who is currently the Distinguished Professor of Radiology at University of Pittsburgh and holds the UPMC Endowed Chair of PET Research. [2] [3] [4]
He is known for is work with William E. Klunk on a PET radiotracer for imaging amyloid, a protein linked to neurodegenerative diseases including Alzheimer’s. His efforts led to the creation of a novel category of high-efficacy radiopharmaceutical agents, for example Pittsburgh Compound-B (PiB), which can be used to assess beta-amyloid in the living human brain using PET scanning, and which is a fluorescent analog of thioflavin T. [3] For his work on Alzheimer's disease he has received the Metlife Foundation Award (2004) [5] and the Potamkin Prize (2008). [6]
Chester A. Mathis | |
---|---|
Education |
Humboldt State University B.Sc. (1972) UC Davis Ph.D. (1979) |
Awards |
Metlife Foundation Award for Medical Research in Alzheimer's Disease
[1] (2004) Potamkin Prize (2008) Reagan Institute Award (2009) |
Scientific career | |
Institutions | University of Pittsburgh Medical Center |
Chester Mathis is an American chemist who is currently the Distinguished Professor of Radiology at University of Pittsburgh and holds the UPMC Endowed Chair of PET Research. [2] [3] [4]
He is known for is work with William E. Klunk on a PET radiotracer for imaging amyloid, a protein linked to neurodegenerative diseases including Alzheimer’s. His efforts led to the creation of a novel category of high-efficacy radiopharmaceutical agents, for example Pittsburgh Compound-B (PiB), which can be used to assess beta-amyloid in the living human brain using PET scanning, and which is a fluorescent analog of thioflavin T. [3] For his work on Alzheimer's disease he has received the Metlife Foundation Award (2004) [5] and the Potamkin Prize (2008). [6]